Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration

@article{Shah2014PreparationIV,
  title={Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration},
  author={Mansi K. Shah and Parshotam L. Madan and Senshang Lin},
  journal={Pharmaceutical Development and Technology},
  year={2014},
  volume={19},
  pages={475 - 485}
}
Abstract Carvedilol-loaded solid lipid nanoparticles (SLNs) were prepared using solubility parameter (δ) to select the lipid, and hot homogenization to fabricate SLNs. The effect of concentration of Compritol 888 ATO (COMP) and Poloxamer 188 (P-188) on the particle size of blank SLNs was studied using the design of experiments. Further narrow concentration range of COMP and P-188 was selected and carvedilol-loaded SLNs were prepared to obtain an optimized formulation which was lyophilized (L… Expand
Rosuvastatin calcium-loaded Solid Lipid Nanoparticles (SLN) using design of experiment approach for oral delivery
This investigation utilizes quality-by-design approach to develop the Rosuvastatin Calcium (Rst)-loaded solid lipid nanoparticles (SLN). Effect of formulation variables such as amount of lipidExpand
Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles
TLDR
Use of the combo experimental design approach enabled clear understanding of the effects of various formulation variables on IMT-SLN and aided in the preparation of a system which exhibited desirable physicochemical and release characteristics. Expand
Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines
TLDR
It is demonstrated that, despite the drug’s affinity to lipids frequently used in SLN production, the curcumin amount loaded in most SLN formulations may be too low to exhibit anticancer properties, substantiating the conclusions thatCurcumin's effect in cancer cells is highly dose dependent. Expand
In silico-in vitro-in vivo studies of experimentally designed carvedilol loaded silk fibroin-casein nanoparticles using physiological based pharmacokinetic model.
TLDR
The enhanced bioavailability with sustained effect demonstrates potential of silk fibroin as an alternative carrier for drug delivery and presents Gastoplus™ as efficient tool for in vivo in silico simulations. Expand
Adaptation of Quality by Design-Based Development of Isradipine Nanostructured-Lipid Carrier and Its Evaluation for In Vitro Gut Permeation and In Vivo Solubilization Fate.
TLDR
Systematic adaptation of quality by design integrated approach improved gut permeation and potential solubilizaton fate (dynamic lipolysis) of ISD-NLC, which further improved the lymphatic uptake and biodistribution of drug thereby promisingits in vivo prospect and clinical efficacy. Expand
Selection of excipients for the development of carvedilol loaded lipid-based drug delivery systems
Carvedilol (CARV) is a widely used drug, which has shown low oral bioavailability. Lipid-based drug delivery systems (LBDDS) appear as promising alternatives to overcome CARV pharmacokinetic issues.Expand
Elucidation of intestinal absorption mechanism of carvedilol-loaded solid lipid nanoparticles using Caco-2 cell line as an in-vitro model
TLDR
The results obtained in this model suggest that main absorption mechanism of FOPT-SLNs could be endocytosis and, more specifically, clathrin-mediated endocyTosis. Expand
Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation
TLDR
The HVD-NLCs were potential carriers for verapamil as they significantly enhanced the cellular uptake of the drug. Expand
Sustained release biodegradable solid lipid microparticles: Formulation, evaluation and statistical optimization by response surface methodology
TLDR
The optimized SLMs have the potential to improve nebivolol oral bioavailability and are analyzed by polynomial equations and the suggested quadratic model were validated. Expand
Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation.
TLDR
The surface-modified PNLCs formulation was an effective, biocompatible, stable formulation in the enhancement of dissolution rate, solubility, stability with reduced mucus adhesion and increased permeability thereby which indicates its enhanced oral bioavailability. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 27 REFERENCES
Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery
TLDR
The results demonstrated that SLNs prepared herein can potentially be exploited as carriers for the oral delivery of vitamin K1 and had an imperfect crystalline lattice and a spherical morphology. Expand
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN).
  • Schwarz, Mehnert
  • Chemistry, Medicine
  • International journal of pharmaceutics
  • 1997
TLDR
The sugar trehalose proved to be most effective in preventing particle growth during freezing and thawing and also in the freeze-drying process and the lyophilisate quality is sufficient for formulations less critical to limited particle growth. Expand
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
TLDR
SLN could be a promising sustained release and targeting system for camptothecin or other lipophilic antitumor drugs after oral administration and show significant changes in body distribution through incorporation into solid lipid nanoparticles by peroral route. Expand
Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery.
TLDR
This review article covers the methods of production, characterization, mechanisms of oral bioavailability enhancement, scale-up, final oral dosage forms, and regulatory aspects of lipid nanoparticles for oral drug delivery using high-pressure homogenization production methods. Expand
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Solid lipid nanoparticles (SLN®), nanostructured lipid carriers (NLC®), and lipid–drug conjugates (LDC®), commonly produced by high-pressure homogenization, are interesting vectors for oral deliveryExpand
Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size.
  • M. Gaumet, R. Gurny, F. Delié
  • Chemistry, Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2009
TLDR
The aim of the present work was to study the influence of the size of well characterized biodegradable polymeric particles on cellular uptake by Caco-2 cells and to estimate the number of particles interacting with a single cell. Expand
Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
TLDR
The PEG and folate modified SLN could enhance the cellular uptake of SLN and the cellular cytotoxicity of drug by the membrane disturb ability of PEG chains on the SLN surface and the improved endocytosis mediated by folate receptor. Expand
Preparation and Evaluation of SEDDS and SMEDDS Containing Carvedilol
TLDR
The developed SEDDS and SMEDDS formulations significantly improved the oral bioavailability of carvedilol significantly, and the relative oral bio availability of SED DS compared with commercially available tablets was 413%. Expand
Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
TLDR
The skin irritation studies carried out on rabbits showed that SLN based TRE gel is significantly less irritating to skin as compared to marketed TRE cream and clearly indicated its potential in improving the skin tolerability of TRE. Expand
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
  • R. Müller, K. Mäder, S. Gohla
  • Medicine
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2000
TLDR
Relevant issues for the introduction of SLN to the pharmaceutical market, such as status of excipients, toxicity/tolerability aspects and sterilization and long-term stability including industrial large scale production are discussed. Expand
...
1
2
3
...